OP-096 PROGNOSTIC ROLE OF PHARMACOLOGICAL AND REVASCULARIZATION TREATMENT IN DIABETIC ISCHEMIC PATIENTS WITH LEFT VENTRICULAR SYSTOLIC DYSFUNCTION

2010 ◽  
Vol 140 ◽  
pp. S28
Author(s):  
Savina Nodari ◽  
Nicola Berlinghieri ◽  
M. Triggiani ◽  
A. Foresti ◽  
A. Manerba ◽  
...  
Keyword(s):  
Left Ventricular Systolic Dysfunction ◽  
Systolic Dysfunction ◽  
Left Ventricular ◽  
Ventricular Systolic Dysfunction ◽  
Prognostic Role

scholarly journals Trimetazidine modified release in treatment of patients with the serious course of chronic ischemic heart disease: from the theory to real clinical practice

2014 ◽  
Vol 5 (1) ◽  
pp. 56-62
Author(s):  
A. V Barsukov ◽  
D. V Glukhovskoy
Keyword(s):  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Left Ventricular Systolic Dysfunction ◽  
Systolic Dysfunction ◽  
Left Ventricular ◽  
Ischemic Heart ◽  
Modified Release ◽  
Ventricular Systolic Dysfunction ◽  
Chronic Ischemic Heart Disease

The paper considers modern conceptions about the role of citoprotective therapy in persons with ischemic heart disease. Special attention is given to the justification of Trimetazidine modified release (TMZ MV) application in patients with severe multi-vessel coronary lesions in conjunction with left ventricular systolic dysfunction. There described the clinical case with emphasis on possibility of inclusion in conservative treatment scheme of TMZ MB to poly morbid elderly patient with severe ischemic heart disease.

Sign in / Sign up

Export Citation Format

Share Document